Healthcare & Life Sciences
Avidity Biosciences
United Stateswww.aviditybiosciences.com/
aliveseries-c-plus
series-c-plus
Stage
4
Investors
About
Avidity Biosciences develops targeted RNA therapeutics using its proprietary Antibody Oligonucleotide Conjugates (AOC) platform to treat rare muscle diseases by targeting the underlying genetic causes.
Explore Avidity Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.